Zi-Fen Su

421 total citations
15 papers, 349 citations indexed

About

Zi-Fen Su is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zi-Fen Su has authored 15 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zi-Fen Su's work include Radiopharmaceutical Chemistry and Applications (12 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Zi-Fen Su is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (12 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Zi-Fen Su collaborates with scholars based in Canada, China and United States. Zi-Fen Su's co-authors include James R. Ballinger, Yuqing Li, C. Shun Wong, Robert Nordal, Mary Rusckowski, Donald J. Hnatowich, Andrew M. Rauth, Zhihong Zhu, Guozheng Liu and Suresh Gupta and has published in prestigious journals such as Bioconjugate Chemistry, European Journal of Nuclear Medicine and Molecular Imaging and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Zi-Fen Su

15 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zi-Fen Su Canada	8	192	104	88	88	56	15	349
Aurélien Vidal France	12	109 0.6×	79 0.8×	94 1.1×	88 1.0×	25 0.4×	27	370
Edward V. Colapinto United States	11	252 1.3×	97 0.9×	90 1.0×	43 0.5×	46 0.8×	13	434
Peter Conti United States	9	232 1.2×	147 1.4×	179 2.0×	81 0.9×	14 0.3×	25	536
Christoph M. Griessinger Germany	12	194 1.0×	196 1.9×	103 1.2×	62 0.7×	16 0.3×	18	514
Manfred Birchler Switzerland	6	197 1.0×	129 1.2×	179 2.0×	34 0.4×	17 0.3×	7	386
Shundong Ji China	13	149 0.8×	122 1.2×	227 2.6×	64 0.7×	11 0.2×	35	500
Pontus K.E. Börjesson Netherlands	8	330 1.7×	189 1.8×	125 1.4×	118 1.3×	10 0.2×	9	522
Raquel J. Nunes Portugal	8	69 0.4×	110 1.1×	138 1.6×	47 0.5×	19 0.3×	14	387
Anna Laura Aloisi Italy	6	97 0.5×	317 3.0×	177 2.0×	87 1.0×	16 0.3×	6	481
Maria-Elena Jockovich United States	13	73 0.4×	132 1.3×	160 1.8×	50 0.6×	38 0.7×	15	404

Countries citing papers authored by Zi-Fen Su

Since Specialization

Citations

This map shows the geographic impact of Zi-Fen Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi-Fen Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi-Fen Su more than expected).

Fields of papers citing papers by Zi-Fen Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi-Fen Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi-Fen Su. The network helps show where Zi-Fen Su may publish in the future.

Co-authorship network of co-authors of Zi-Fen Su

This figure shows the co-authorship network connecting the top 25 collaborators of Zi-Fen Su. A scholar is included among the top collaborators of Zi-Fen Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi-Fen Su. Zi-Fen Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ponde, Datta E., Zi-Fen Su, Alan Berezov, et al.. (2011). Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent. Bioorganic & Medicinal Chemistry Letters. 21(8). 2550–2553. 6 indexed citations

Xu, Yong, Suzhen Zhang, Canhua Huang, et al.. (2009). Keratin 17 identified by proteomic analysis may be involved in tumor angiogenesis. BMB Reports. 42(6). 344–349. 7 indexed citations

Su, Zi-Fen, et al.. (2008). Possible mechanisms of controlling the configuration, stability, and lipophilicity of [^99mTcO]N₃S and [ReO]N₃S chelates. Journal of Labelled Compounds and Radiopharmaceuticals. 51(2). 93–100. 3 indexed citations

Li, Li, et al.. (2007). The correlation of serum protein association and cellular uptake with lipophilicity and polarity of the backbone substituents of the technetium‐99m‐amine‐oxime chelates. Journal of Labelled Compounds and Radiopharmaceuticals. 50(2). 91–95. 2 indexed citations

Su, Zi-Fen. (2006). Development of radiolabeled peptides to target p185HER2/neu receptors of cancer. Journal of Labelled Compounds and Radiopharmaceuticals. 49(14). 1259–1271. 2 indexed citations

Su, Zi-Fen, Jiang He, Mary Rusckowski, & Donald J. Hnatowich. (2003). In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands. Nuclear Medicine and Biology. 30(2). 141–149. 30 indexed citations

Su, Zi-Fen, Guozheng Liu, Suresh Gupta, et al.. (2002). In Vitro and in Vivo Evaluation of a Technetium-99m-Labeled Cyclic RGD Peptide as a Specific Marker of α_Vβ₃ Integrin for Tumor Imaging. Bioconjugate Chemistry. 13(3). 561–570. 81 indexed citations

Li, Yuqing, James R. Ballinger, Robert Nordal, Zi-Fen Su, & C. Shun Wong. (2001). Hypoxia in radiation-induced blood-spinal cord barrier breakdown.. PubMed. 61(8). 3348–54. 112 indexed citations

Wang, Judy, Paul Chen, Zi-Fen Su, et al.. (2001). Amplified delivery of indium-111 to EGFR-positive human breast cancer cells. Nuclear Medicine and Biology. 28(8). 895–902. 11 indexed citations

10.

Utsunomiya, Keita, James R. Ballinger, Micheline Piquette‐Miller, et al.. (2000). Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line. European Journal of Nuclear Medicine and Molecular Imaging. 27(12). 1786–1792. 34 indexed citations

11.

Zhang, Xiuguo, Zi-Fen Su, James R. Ballinger, et al.. (2000). Targeting Hypoxia in Tumors Using 2-Nitroimidazoles with Peptidic Chelators for Technetium-99m: Effect of Lipophilicity. Bioconjugate Chemistry. 11(3). 401–407. 23 indexed citations

12.

Su, Zi-Fen, et al.. (2000). A Novel Amine−Dioxime Chelator for Technetium-99m: Synthesis and Evaluation of 2-Nitroimidazole-Containing Analogues as Markers for Hypoxic Cells. Bioconjugate Chemistry. 11(5). 652–663. 18 indexed citations

13.

Su, Zi-Fen, Xiu-Guo Zhang, James R. Ballinger, et al.. (1999). Synthesis and Evaluation of Two Technetium-99m-Labeled Peptidic 2-Nitroimidazoles for Imaging Hypoxia. Bioconjugate Chemistry. 10(5). 897–904. 15 indexed citations

14.

Schwochau, K., et al.. (1992). Synthesis, characterization and biodistribution of the cationic technetium(II), 1,10-phenanthroline chelate. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 43(9). 1079–1082. 4 indexed citations

15.

Su, Zi-Fen, et al.. (1992). Preparation and evaluation of cationic ⁹⁹Tc/^99mTc dimethoxy‐ and diethoxy‐hexanedione dioxime complexes. Journal of Labelled Compounds and Radiopharmaceuticals. 31(1). 61–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact